<span style="display: block; margin-top: 60px;">Time to Think<span style="font-size: 0.6em; display: block; margin: 5px 0;">Time in Range</span></span>

InRange - the first randomised, Phase 4 study to use Time-In-Range (TIR) as the primary endpoint to compare second generation basal insulin analogues Toujeo and insulin degludec 100U/mL in people with T1DM

Time-in-Range Study Design

Watch this 2.30 min video on the InRange* study design. Alternatively, you can also download the published paper below.

Published study design


*The InRange study has been sponsored by Sanofi

Time in Range Guide

View the guide below to find out more about the impact of time in range on your patients. 

View Guide

Lady talking on phone

Always up to date?

Webinars, evidence, expert videos, peer-to-peer events… Do you want to be the first to know when new, relevant information is available? Let us know and we’ll send you a message. 

This site uses cookies to store information on your computer. Some cookies on this site are needed because the site won’t work as expected without them. To learn more about cookies, please read our Cookie Policy.
By closing this message or using the website, you agree to our use of cookies on this device in agreement with our Cookie Policy, unless you have turned them off.
Accept and close